🇺🇸 FDA
Patent

US 11304950

Methods for treating testicular and ovarian adrenal rest tumors

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 11304950 (Methods for treating testicular and ovarian adrenal rest tumors) held by SPRUCE BIOSCIENCES, INC. expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SPRUCE BIOSCIENCES, INC.
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/519, A61K31/5377, A61K45/06, A61K9/0053